The Health­care Sector in the Shadow of AI: When Will Investor Interest Return?

The problem with the health­care sector is not that its long-term funda­men­tals have disap­peared. An aging popula­tion, chronic diseases, innova­tion, and the need to control system-wide costs are still very much present. Rather, the casual investor currently has little reason to look beyond AI. Has the health­care sector been cast into the shadows—fundamentally sound, but largely forgotten?

What about demand?

One of the key questions at the confe­rence was whether demand in the health­care sector is now slowing down after several years of strong growth. This concern is under­stan­dable: Higher insurance premiums and higher out-of-pocket costs may lead consu­mers to become more selec­tive, which could be reflected in their use of health­care services. The first quarter of 2026 provided no clear indica­tions. A mild flu season, winter storms, and better-than-expected medical loss ratios at managed care compa­nies made it diffi­cult to assess the actual under­lying trend. As a result, the second-quarter reports take on greater signi­fi­cance.

However, the health­care sector is not a homoge­neous consumer category. A large portion of the demand is govern­ment-funded, chronic, acute, or medically neces­sary. The risk, there­fore, lies less in a sharp decline in demand and more in a norma­lization from an elevated level. Fortu­n­a­tely, several compa­nies at the confe­rence indicated that they expect a recovery in utilization for the second quarter of 2026.

The evalua­tion alone is not enough

Valua­tion is another important aspect of the debate. Several subsec­tors of the health­care industry currently appear underva­lued relative to their own histo­rical perfor­mance or the overall market. This is parti­cu­larly evident in medical techno­logy, where slowing growth, some negative earnings revisions, and compe­ti­tion from other invest­ment themes have had a signi­fi­cant impact on market senti­ment.

However, a low valua­tion is rarely a trigger in and of itself. While it can lay the ground­work for better future returns, underva­lued stocks and sectors can remain in this state for a long time.

The missing trigger might be right under our noses

In theory, the sector needs a catalyst. In practice, however, that catalyst could lie outside the health­care sector. As long as AI-related stocks attract the bulk of the market’s atten­tion, the steady growth in health­care may seem unspec­ta­cular to general investors. However, should AI’s leading role expand, stall, or disap­point, the “boring” charac­te­ri­stics of the health­care sector—visible cash flows and resilient demand—could regain their appeal.

The health­care sector has histo­ri­cally performed well in turbu­lent markets and has served as the market’s “fire insurance.” The problem is not that the insurance no longer works. The problem is that investors currently do not believe there is a fire—despite geopo­li­tical turmoil, fiscal pressures, and political uncer­tainty.

Nevert­heless, the old mecha­nism appears to be intact: When volati­lity increased in the first week of June 2026, the health­care sector once again began to act as a stabi­li­zing force.

Could a rotation into AI stocks give the health­care sector a new boost?

The health­care sector remains a sector with strong long-term struc­tural drivers, but struc­tural arguments alone are not enough at this time. Investors want evidence that demand is resilient, that estimates are reali­stic, and that capital is allocated in a share­holder-friendly manner.

The good news is that expec­ta­tions are low after a long period of under­per­for­mance. The less encou­ra­ging reality is that much of the recovery could depend on something health­care compa­nies cannot control: whether investors begin to look beyond AI again. For us, there­fore, the question is not whether the health­care sector will regain its place in the sun, but when investors will start looking beyond AI.